Ge Shengjie, Li Guang, Zhou Xinyu, Mao Yu, Gu Yingyan, Li Zhiyue, Gu Yuexing, Cao Xiaowei
Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, PR China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, PR China; Jiangsu Key Laboratory of Experimental & Translational Noncoding RNA Research, Medical College, Yangzhou University, Yangzhou, China.
Department of Otorhinolaryngology-Head and Neck Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225001, PR China.
Talanta. 2022 Aug 1;245:123478. doi: 10.1016/j.talanta.2022.123478. Epub 2022 Apr 12.
MicroRNA (miRNA), as one of the ideal target biomarker analytes, plays an essential role in biological processes; thus, the development of rapidly sensitive detection methods is imperative. Herein, we proposed a pump-free surface-enhanced Raman scatting (SERS) microfluidic chip for the rapid and ultrasensitive detection of miR-106b and miR-196b, laryngeal squamous cell carcinoma (LSCC)-related miRNAs. Ag-Au core-shell nanorods (Ag-AuNRs) were applied to prepare SERS tags by modifying Raman reporters and hairpin DNAs. The capture probes were synthesized by labeling hairpin DNAs onto the magnetic beads (MBs) surface. In the presence of targets, the catalytic hairpin assembly (CHA) reactions between SERS tags and capture probes could be triggered, causing the aggregation of Ag-AuNRs. The tiny magnets installed under the rectangular chamber could magnetically gather the CHA products, leading to the further aggregation of Ag-AuNRs. Thus, this strategy could achieve the double aggregation of Ag-AuNRs, resulting in the significant amplification of the SERS signal. The proposed strategy achieved simultaneous and sensitive detection of miR-106b and miR-196b, with limits of detection low to aM level. The whole detection process could be completed within 5 min. Moreover, this microfluidic chip exhibited excellent reproducibility, stability, and specificity. The high accuracy of this SERS microfluidic chip was proved by practical analysis in LSCC patients' serum. The results demonstrated that SERS could be a promising alternative clinical diagnosis tool and exhibited potential application for the dynamic monitoring of cancer staging.
微小RNA(miRNA)作为理想的靶标生物标志物分析物之一,在生物过程中起着至关重要的作用;因此,开发快速灵敏的检测方法势在必行。在此,我们提出了一种无泵表面增强拉曼散射(SERS)微流控芯片,用于快速、超灵敏地检测与喉鳞状细胞癌(LSCC)相关的miR-106b和miR-196b。通过修饰拉曼报告分子和发夹DNA,应用银-金核壳纳米棒(Ag-AuNRs)制备SERS标签。通过将发夹DNA标记在磁珠(MBs)表面合成捕获探针。在靶标存在的情况下,可触发SERS标签与捕获探针之间的催化发夹组装(CHA)反应,导致Ag-AuNRs聚集。安装在矩形腔室下方的小磁铁可磁性收集CHA产物,导致Ag-AuNRs进一步聚集。因此,该策略可实现Ag-AuNRs的双重聚集,从而显著放大SERS信号。所提出的策略实现了对miR-106b和miR-196b的同时灵敏检测,检测限低至aM水平。整个检测过程可在5分钟内完成。此外,该微流控芯片具有出色的重现性、稳定性和特异性。通过对LSCC患者血清的实际分析,证明了该SERS微流控芯片的高准确性。结果表明,SERS可能是一种有前途的替代临床诊断工具,并在癌症分期的动态监测中显示出潜在应用。